Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea · Delayed Price · Currency is KRW 84,900
-500 (-0.59%)
At close: Jul 22, 2025, 3:30 PM KST
Chong Kun Dang Pharmaceutical Company Description
Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.
It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair color medication, as well as insecticides.
The company also exports its products. Chong Kun Dang Pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
Chong Kun Dang Pharmaceutical Corp.
| Country | South Korea |
| Founded | 1941 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,281 |
| CEO | Young-Joo Kim |
Contact Details
Address: 8, Chungjeong-ro Seoul South Korea | |
| Phone | 82 2 6373 0600 |
| Website | ckdpharm.com |
Stock Details
| Ticker Symbol | 185750 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7185750007 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Young-Joo Kim | President, Chief Executive Officer and Chairman |